A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty

Clinical trial NCT07710430 · RECRUITING

Trial details

NCT number: NCT07710430
Sponsor: LG Chem
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Central Precocious Puberty

Start date: 2026-08-01
Primary completion: 2029-08-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.